Answers are grounded in this paper and cite their sources.
Narrative review highlights reproductive outcomes and sperm retrieval methods in males with cystic fibrosis, suggesting improved practices with modulator therapy.
• Teaching Points. • 98% of males with CF have obstructive azoospermia due to congenital bilateral absence of the vas deferens and epididymal hypoplasia; many also experience low ejaculatory volume due to hypoplasia of the seminal vesicles and ejaculatory duct obstruction. Basic science studies suggest poor sperm production, although this is poorly studied in males with CF. • There are many methods for sperm retrieval in males with CF; retrieved sperm must be used for in vitro fertilization with intracytoplasmic sperm injection (ICSI). Live birth rates per ICSI cycle range from 33-84%. • Future studies are needed to understand the impact of highly effective modulator therapy on sperm quality, sperm retrieval, and reproductive outcomes in couples where the male partner is affected by CF. Teaching Points. 98% of males with CF have obstructive azoospermia due to congenital bilateral absence of the vas deferens and epididymal hypoplasia; many also experience low ejaculatory volume due to hypoplasia of the seminal vesicles and ejaculatory duct obstruction. Basic science studies suggest poor sperm production, although this is poorly studied in males with CF. There are many methods for sperm retrieval in males with CF; retrieved sperm must be used for in vitro fertilization with intracytoplasmic sperm injection (ICSI). Live birth rates per ICSI cycle range from 33-84%. Future studies are needed to understand the impact of highly effective modulator therapy on sperm quality, sperm retrieval, and reproductive outcomes in couples where the male partner is affected by CF. We aim to summarize the current knowledge of fertility in males with Cystic Fibrosis (MwCF) including reproductive outcomes, the role of the CFTR mutation in sperm function, patient perspectives for MwCF and review future directions. This narrative review synthesizes current literature and clinical guidance regarding male infertility in MwCF. Primary sources were identified through targeted database searches and cross-referencing bibliographies of landmark studies. Emphasis was placed on high-impact original research and clinical research that have shaped current practice. MwCF must undergo surgical sperm retrieval along with intracytoplasmic sperm injection (ICSI) to have a biological child. Emerging research suggests that this anatomic anomaly may not be the only contributing factor to male fertility outcomes. Several studies have demonstrated spermatogenic dysfunction in MwCF. Limited data exists regarding assisted reproductive outcomes in MwCF and much of this data was published prior to the advent of modulator therapy (MT), raising the question as to whether these findings are applicable to today’s patients. Additionally, hypogonadism may be more prevalent in MwCF compared to the general population, yet no guidance exists on screening, leading to missed opportunities to improve quality of life and other physiologic benefits. Given the necessity for assisted reproduction for MwCF, early diagnosis and referral to a reproductive urologist are critical for helping patients navigate the logistical challenges of biological fatherhood. Proactive counseling from adolescence ensures that families can realistically prepare for the emotional, surgical and financial complexities of the reproductive journey.
No takes yet. Share an insight, caveat, or question.
Vij et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: